Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.
Cureus September 17, 2025 Arya Kermanshah, Margo Stapleton, Christine M Mauriello et al. 1 citation
Ayahuasca, a brew containing N,N-dimethyltryptamine (DMT) with monoamine oxidase-inhibiting β-carbolines, has expanded from traditional use to global retreats. Reported adverse effects include vomiting, agitation, serotonin toxicity-like syndromes, and cardiovascular events. Rhabdomyolysis has been described with other classic hallucinogens (e.g., lysergic acid diethylamide and psilocybin),...
DOI: 10.7759/cureus.92568 (opens in new tab)
Full text (opens in new tab)
Ayahuasca side effects
Ayahuasca toxicity
Ayahuasca risks
Kidney failure
+12